MOSPD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.036800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.801800E-01
Normal-vs-Stage2
6.314000E-01
Normal-vs-Stage3
8.236000E-01
Normal-vs-Stage4
4.278200E-01
Stage1-vs-Stage2
3.049200E-01
Stage1-vs-Stage3
9.237200E-01
Stage1-vs-Stage4
2.212400E-01
Stage2-vs-Stage3
4.478400E-01
Stage2-vs-Stage4
5.321200E-01
Stage3-vs-Stage4
2.775600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.707400E-01
Normal-vs-AfricanAmerican
1.680810E-01
Normal-vs-Asian
4.397200E-01
Caucasian-vs-AfricanAmerican
9.322000E-02
Caucasian-vs-Asian
2.613000E-01
AfricanAmerican-vs-Asian
5.030000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.471800E-01
Normal-vs-Female
6.313200E-01
Male-vs-Female
7.551800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.814600E-01
Normal-vs-Age(41-60Yrs)
3.255200E-01
Normal-vs-Age(61-80Yrs)
9.127600E-01
Normal-vs-Age(81-100Yrs)
9.540000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.576600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.811200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.446000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.079080E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.331800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.389000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.816600E-01
Normal-vs-Daily Drinker
8.718200E-01
Normal-vs-Weekly Drinker
3.939000E-01
Normal-vs-Occasional Drinker
4.786600E-01
Normal-vs-Social Drinker
9.353800E-01
Non Drinker-vs-Daily Drinker
5.023000E-01
Non Drinker-vs-Weekly Drinker
1.494170E-01
Non Drinker-vs-Occasional Drinker
1.620580E-01
Non Drinker-vs-Social Drinker
8.911400E-01
Daily Drinker-vs-Weekly Drinker
1.019040E-01
Daily Drinker-vs-Occasional Drinker
8.195700E-02
Daily Drinker-vs-Social Drinker
6.566200E-01
Weekly Drinker-vs-Occasional Drinker
8.047400E-01
Weekly Drinker-vs-Social Drinker
1.611600E-01
Occasional Drinker-vs-Social Drinker
1.572250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.086400E-01
Normal-vs-Grade 2
8.086000E-01
Normal-vs-Grade 3
5.259600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.758400E-02
Grade 1-vs-Grade 3
1.160400E-01
Grade 1-vs-Grade 4
9.086400E-01
Grade 2-vs-Grade 3
9.159200E-01
Grade 2-vs-Grade 4
8.086000E-01
Grade 3-vs-Grade 4
5.259600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.923400E-01
Normal-vs-NonDiabetic
7.033600E-01
Diabetic-vs-NonDiabetic
2.071600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.536200E-01
Normal-vs-NoPancreatitis
7.662200E-01
Pancreatitis-vs-NoPancreatitis
9.836200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.308200E-01
Normal-vs-N1
6.002400E-01
N0-vs-N1
1.105400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.446400E-01
Normal-vs-TP53-NonMutant
6.756000E-01
TP53-Mutant-vs-TP53-NonMutant
4.275200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
